Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership114,487 shares
Latest Disclosed Value $ 127,081
Citadel Advisors Llc ownership in 10V / Immunic, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 114,487 shares of Immunic, Inc. (DE:10V) valued at $127,081 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 266,806 shares of Immunic, Inc.. This represents a change in shares of -57.09% during the quarter. The current value of the position is $1,904,148 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (10V) in the form of stock options. The firm currently holds call options representing 115,600 of underlying shares valued at $128,316 USD and put options representing 31,300 of underlying shares valued at $34,743 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:10V / Immunic, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNIC COM 4525EP101 114,487 -152,319 -57.09 127 -10.56 0.0000
2026-02-17 2025-12-31 13F IMMUNIC COM 4525EP101 266,806 -268,277 -50.14 142 -69.85 0.0000
2025-11-14 2025-09-30 13F IMMUNIC COM 4525EP101 535,083 535,083 472 0.0001
2025-05-15 2025-03-31 13F IMMUNIC COM 4525EP101 0 -300 -100.00 0 0.0000
2025-02-14 2024-12-31 13F IMMUNIC COM 4525EP101 300 -239,757 -99.88 0 -100.00 0.0000
2024-11-14 2024-09-30 13F IMMUNIC COM 4525EP101 240,057 240,055 12,002,750.00 396 0.0001
2024-08-14 2024-06-30 13F IMMUNIC COM 4525EP101 2 0 0.00 0 0.0000
2024-05-15 2024-03-31 13F IMMUNIC COM 4525EP101 2 2 0 0.0000
2023-11-14 2023-09-30 13F IMMUNIC COM 4525EP101 0 -1,879 -100.00 0 -100.00
2023-08-14 2023-06-30 13F IMMUNIC COM 4525EP101 1,879 -6,101 -76.45 5 -63.64 0.0000
2023-05-15 2023-03-31 13F IMMUNIC COM 4525EP101 7,980 -17,224 -68.34 12 -68.57 0.0000
2023-02-14 2022-12-31 13F IMMUNIC COM 4525EP101 25,204 25,204 35 0.0000
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 0 -496,554 -100.00 0 -100.00
2022-08-15 2022-06-30 13F IMMUNIC COM 4525EP101 496,554 462,178 1,344.48 1,723 342.93 0.0004
2022-05-16 2022-03-31 13F IMMUNIC COM 4525EP101 34,376 -10,236 -22.94 389 -8.90 0.0001
2022-02-14 2021-12-31 13F IMMUNIC COM 4525EP101 44,612 44,612 427 0.0001
2022-03-11 2021-09-30 13F/A-1 IMMUNIC COM 4525EP101 0 -13,909 -100.00 0 -100.00
2021-11-15 2021-09-30 13F IMMUNIC COM 4525EP101 0 -13,909 0
2021-08-16 2021-06-30 13F IMMUNIC COM 4525EP101 13,909 13,909 171 0.0000
2021-05-21 2021-03-31 13F/A-1 IMMUNIC COM 4525EP101 0 -23,128 -100.00 0 -100.00
2021-02-16 2020-12-31 13F IMMUNIC COM 4525EP101 23,128 -4,975 -17.70 353 -32.38 0.0001
2020-11-16 2020-09-30 13F IMMUNIC COM 4525EP101 28,103 28,103 21.51 522 47.88 0.0001
2019-08-14 2019-06-30 13F VITAL THERAPIES Cmn 92847R104 0 -57,591 -100.00 0 -100.00
2019-05-15 2019-03-31 13F VITAL THERAPIES Cmn 92847R104 57,591 -13,108 -18.54 11 -15.38 0.0000
2019-02-14 2018-12-31 13F VITAL THERAPIES Cmn 92847R104 70,699 -225,905 -76.16 13 -84.15 0.0000
2018-11-13 2018-09-30 13F VITAL THERAPIES Cmn 92847R104 296,604 260,821 728.90 82 -66.53 0.0000
2018-08-14 2018-06-30 13F/A-1 VITAL THERAPIES Cmn 92847R104 35,783 35,783 -87.94 245 198.78 0.0001
2018-08-10 2018-06-30 13F VITAL THERAPIES Cmn 92847R104 35,783 35,783 245
2018-05-14 2018-03-31 13F/A-1 VITAL THERAPIES Cmn 92847R104 0 -38,569 -100.00 0 -100.00
2018-02-09 2017-12-31 13F VITAL THERAPIES Cmn 92847R104 38,569 38,569 229 0.0001
2016-05-13 2016-03-31 13F VITAL THERAPIES Cmn 92847R104 0 -21,351 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 VITAL THERAPIES Cmn 92847R104 21,351 21,351 388.92 246 167.39 0.0003
2016-02-12 2015-12-31 13F VITAL THERAPIES Cmn 92847R104 21,351 246
2015-11-16 2015-09-30 13F VITAL THERAPIES Cmn 92847R104 0 -4,367 -100.00 0 -100.00
2015-08-14 2015-06-30 13F VITAL THERAPIES Cmn 92847R104 4,367 4,367 92 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNIC COM Call 115,600 24.57 128 161.22 n/a n/a n/a
2026-02-17 2025-12-31 13F IMMUNIC COM Call 92,800 127.45 50 40.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNIC COM Call 40,800 209.09 36 288.89 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNIC COM Call 13,200 2,100.00 9 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNIC COM Call 600 -82.86 1 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNIC COM Call 3,500 3,400.00 4 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNIC COM Call 100 -97.87 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNIC COM Call 4,700 683.33 5 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNIC COM Call 600 -89.47 1 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNIC COM Call 5,700 -41.84 9 -42.86 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNIC COM Call 9,800 -85.44 14 -91.67 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNIC COM Call 67,300 2,392.59 169 4,100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F IMMUNIC COM Call 2,700 -97.03 4 -96.85 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNIC COM Call 91,000 0.66 127 -55.59 n/a n/a n/a
2022-11-14 2022-09-30 13F IMMUNIC COM Call 90,400 -55.71 286 -59.60 n/a n/a n/a
2022-08-15 2022-06-30 13F IMMUNIC COM Call 204,100 135.68 708 -27.68 n/a n/a n/a
2022-05-16 2022-03-31 13F IMMUNIC COM Call 86,600 203.86 979 258.61 n/a n/a n/a
2022-02-14 2021-12-31 13F IMMUNIC COM Call 28,500 -11.21 273 -3.87 n/a n/a n/a
2021-11-15 2021-09-30 13F IMMUNIC Cmn Call 32,100 -30.82 284 -50.09 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNIC COM Call 46,400 7.66 569 -17.18 n/a n/a n/a
2021-05-21 2021-03-31 13F/A IMMUNIC COM Call 43,100 29.80 687 35.24 n/a n/a n/a
2021-05-17 2021-03-31 13F IMMUNIC COM Call 43,100 687 n/a n/a n/a
2021-02-16 2020-12-31 13F IMMUNIC COM Call 33,204 31.24 508 8.09 n/a n/a n/a
2020-11-16 2020-09-30 13F IMMUNIC COM Call 25,300 -23.80 470 -7.48 n/a n/a n/a
2019-08-14 2019-06-30 13F VITAL THERAPIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F VITAL THERAPIES Cmn Call 10,300 -58.63 2 -60.00 n/a n/a n/a
2019-02-14 2018-12-31 13F VITAL THERAPIES Cmn Call 24,900 -64.38 5 -73.68 n/a n/a n/a
2018-11-13 2018-09-30 13F VITAL THERAPIES Cmn Call 69,900 175.20 19 -89.08 n/a n/a n/a
2018-08-14 2018-06-30 13F/A VITAL THERAPIES Cmn Call 25,400 -63.66 174 815.79 n/a n/a n/a
2018-08-10 2018-06-30 13F VITAL THERAPIES Cmn Call 25,400 174 n/a n/a n/a
2017-05-12 2017-03-31 13F VITAL THERAPIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-10 2016-12-31 13F VITAL THERAPIES Cmn Call 15,700 -22.28 68 -45.16 n/a n/a n/a
2017-01-31 2016-09-30 13F/A VITAL THERAPIES Cmn Call 20,200 -7.76 124 -8.82 n/a n/a n/a
2016-11-10 2016-09-30 13F VITAL THERAPIES Cmn Call 20,200 124 n/a n/a n/a
2017-01-31 2016-06-30 13F/A VITAL THERAPIES Cmn Call 21,900 8.42 136 9.68 n/a n/a n/a
2016-08-12 2016-06-30 13F VITAL THERAPIES Cmn Call 21,900 136 n/a n/a n/a
2016-05-13 2016-03-31 13F VITAL THERAPIES Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A VITAL THERAPIES Cmn Call 26,800 -52.48 309 35.53 n/a n/a n/a
2016-02-12 2015-12-31 13F VITAL THERAPIES Cmn Call 26,800 309 n/a n/a n/a
2015-11-16 2015-09-30 13F VITAL THERAPIES Cmn Call 56,400 286.30 228 -25.97 n/a n/a n/a
2015-08-14 2015-06-30 13F VITAL THERAPIES Cmn Call 14,600 308 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNIC COM Put 31,300 -22.72 35 61.90 n/a n/a n/a
2026-02-17 2025-12-31 13F IMMUNIC COM Put 40,500 -15.45 22 -50.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNIC COM Put 47,900 169.10 42 250.00 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNIC COM Put 17,800 -66.79 12 -79.31 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNIC COM Put 53,600 -60.67 58 -57.35 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNIC COM Put 136,300 52.80 136 -7.48 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNIC COM Put 89,200 7.60 147 59.78 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNIC COM Put 82,900 10.24 92 -7.07 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNIC COM Put 75,200 -4.93 99 -16.10 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNIC COM Put 79,100 53.00 119 57.33 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNIC COM Put 51,700 -12.96 76 -49.66 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNIC COM Put 59,400 -37.74 149 4.93 n/a n/a n/a
2023-05-15 2023-03-31 13F IMMUNIC COM Put 95,400 117.31 142 132.79 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNIC COM Put 43,900 80.66 61 -20.78 n/a n/a n/a
2022-11-14 2022-09-30 13F IMMUNIC COM Put 24,300 -41.73 77 -46.90 n/a n/a n/a
2022-08-15 2022-06-30 13F IMMUNIC COM Put 41,700 -21.62 145 -75.87 n/a n/a n/a
2022-05-16 2022-03-31 13F IMMUNIC COM Put 53,200 601 n/a n/a n/a
2022-03-11 2021-09-30 13F/A IMMUNIC COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F IMMUNIC COM Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F IMMUNIC COM Put 18,100 222 n/a n/a n/a
2019-05-15 2019-03-31 13F VITAL THERAPIES Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F VITAL THERAPIES Cmn Put 20,000 -82.55 4 -87.50 n/a n/a n/a
2018-11-13 2018-09-30 13F VITAL THERAPIES Cmn Put 114,600 354.76 32 -81.50 n/a n/a n/a
2018-08-14 2018-06-30 13F/A VITAL THERAPIES Cmn Put 25,200 -78.01 173 440.63 n/a n/a n/a
2018-08-10 2018-06-30 13F VITAL THERAPIES Cmn Put 25,200 173 n/a n/a n/a
2016-05-13 2016-03-31 13F VITAL THERAPIES Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A VITAL THERAPIES Cmn Put 2,200 -37.14 25 78.57 n/a n/a n/a
2016-02-12 2015-12-31 13F VITAL THERAPIES Cmn Put 2,200 25 n/a n/a n/a
2015-11-16 2015-09-30 13F VITAL THERAPIES Cmn Put 3,500 -32.69 14 -87.27 n/a n/a n/a
2015-08-14 2015-06-30 13F VITAL THERAPIES Cmn Put 5,200 110 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.